Search Results

Containing any of the words

Only of the type

WATCHMAN FLX versus NOAC for EMbolic ProtectION in the Management of Patients with Non-Valvular Atrial Fibrillation. Clinical Trial

SAFETY AND THERAPEUTIC MEASURES OF TDCS IN PATIENTS WITH REFRACTORY EPILEPSY Clinical Trial

The SFDA Grants Breakthrough Designation to “MIQNAF” for Acute Bacterial Infections Treatment News

Novel assessment and intervention to improve balance and assess peripheral neuropathy in DPN patients Clinical Trial

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) Clinical Trial

SFDA CEO Extends Eid al-Adha Greetings to the Saudi Leadership and Pilgrims News

Tolvaptan Risk Minimization Activity - New

Tocilizumab Risk Minimization Activity - New

Recently Approved Medical Devices from Regulatory Authorities News

The SFDA had a Congratulatory Party During Adha Eid Days for its Employees News